Author

Veerle Bulteel

Observed names: Bulteel, V., Bulteel, Veerle, V BULTEEL, V. Bulteel

Observed institutions: Universitair Ziekenhuis Leuven, European Cystic Fibrosis Society, KU Leuven

ORCID: 0000-0003-0922-6199

Observed ORCID: 0000-0003-0922-6199

OpenAlex ID: A5055529697

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

2002 · Peter Suenaert, Veerle Bulteel, et al. · The American Journal of Gastroenterology · 419

Anti-Saccharomyces Cerevisiae Antibodies (ASCA), Phenotypes of IBD, and Intestinal Permeability: A Study in IBD Families

2001 · Severine Vermeire, Marc Peeters, et al. · Inflammatory Bowel Diseases · 185

Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway

2011 · V. De Preter, K. P. Geboes, et al. · Alimentary Pharmacology & Therapeutics · 50

PDF

2008 · Vicky De Preter, Veerle Bulteel, et al. · Inflammatory Bowel Diseases · 43

Hyperresponsiveness of the Mucosal Barrier in Crohnʼs Disease Is Not Tumor Necrosis Factor-Dependent

2005 · Peter Suenaert, Veerle Bulteel, et al. · Inflammatory Bowel Diseases · 36

Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society–Clinical Trials Network (ECFS-CTN)

2011 · K. De Boeck, V. Bulteel, et al. · Journal of Cystic Fibrosis · 28

PDF

Effects of T cell-induced colonic inflammation on epithelial barrier function†

2010 · Peter Suenaert, Philippe Maerten, et al. · Inflammatory Bowel Diseases · 27

In vivo Influence of Nicotine on Human Basal and NSAID-induced Gut Barrier Function

2003 · P. Suenaert, V. Bulteel, et al. · Scandinavian Journal of Gastroenterology · 25

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network

2020 · Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, et al. · European Respiratory Journal · 17

PDF

Disease-specific clinical trials networks: the example of cystic fibrosis

2016 · Kris De Boeck, Veerle Bulteel, et al. · European Journal of Pediatrics · 15

PDF

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures

2021 · Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, et al. · Trials · 9

PDF

“Il faut continuer à poser des questions” patient reported outcome measures in cystic fibrosis: An anthropological perspective

2021 · Rosa Coucke, Audrey Chansard, et al. · Journal of Cystic Fibrosis · 6

The European Cystic Fibrosis Society–Clinical Trials Network: an international network to optimize clinical research for a rare disease

2013 · Isabelle Fajac, Veerle Bulteel, et al. · Clinical Investigation · 4

Anti-TNF treatment restores the gut barrier in Crohn's disease

2001 · P SUENAERT, V BULTEEL, et al. · Gastroenterology · 4

P062 Impact of the SARS-CoV-2 pandemic on clinical trials in the ECFS-CTN during 2020

2021 · S. Van Koningsbruggen-Rietschel, V. Bulteel, et al. · Journal of Cystic Fibrosis · 1

ECFS Clinical Trials Network annual report 2022

2023 · Downey, Damian; id_orcid 0000-0002-6471-549X, Dunlevy, Fiona, et al. · Research Portal (Queen's University Belfast)

P050 Writing with patients, for patients: co-creation of a cystic fibrosis plain language glossary

2022 · K. Hayes, F. Dunlevy, et al. · Journal of Cystic Fibrosis

European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN): structure and impact since 2009

2020 · Silke Van Koningsbruggen-Rietschel, Damian G. Downey, et al. · European Respiratory Journal

Developing an international network for clinical research: the European Cystic Fibrosis Society – Clinical Trials Network experience

2011 · Veerle Bulteel, Carlo Castellani, et al. · Clinical Investigation

Biphasic impairment of the mucosal barrier function in rat small bowel in vitro by TNF

2003 · Peter Suenaert, Veerle Bulteel, et al. · Gastroenterology

PDF

CD4 T cells regulate epithelial and subepithelial colonic barrier function in SCID mice

2003 · Peter Suenaert, Philippe Maerten, et al. · Gastroenterology

PDF

Gut barrier hyperresponsiveness to indomethacin is limited to the epithelium in colitis in SCID mice reconstituted with CD4CD45RBhigh T cells

2003 · Peter Suenaert, Philippe Maerten, et al. · Gastroenterology

Influence of nicotine on the intestinal transit of a liquid meal

2000 · Peter Suenaert, Veerle Bulteel, et al. · Gastroenterology

2000 · Veerle Bulteel, Peter Suenaert, et al. · Gastroenterology

How useful is sucralose as permeability marker for the human small intestine and colon?

2000 · Peter Suenaert, Veerle Bulteel, et al. · Gastroenterology

Works count: 29

Citation count: 869

H-index: 10

I10-index: 10